Q: I have held Envista for some time, as I am familiar with its suite of products; many of which are considered among best-in-class in dentistry. The share price has declined substantially in the last twelve months. I would like to know if the underlying business has substantially deteriorated, or if there are signs that the company can right itself within the next twelve to twenty-four months. As always, I appreciate any insight you have to offer. Thanks so much, and I look forward to hearing back from you.

Q: Hi 5i,

I found the Q&A about Envista this morning very interesting. With the Veralto spinoff that is happening with DHR, do you think that Veralto will have the same low/no growth issues? I think DHR is trying to do the same again by keeping the higher growth assets and spinning off the lower growth ones. Would you hang on the the new shares when received or would you sell and maybe put back into DHR instead? TIA!


Wayne

Q: Would you consider this company having a reasonable prospect for growth and valuation recovery long- term? Would you consider starting a position in it and accumulating the dental company stock at this time ?